Page last updated: 2024-09-03

gyki 53655 and Drug Withdrawal Symptoms

gyki 53655 has been researched along with Drug Withdrawal Symptoms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rasmussen, K; Vandergriff, J	1

Other Studies

1 other study(ies) available for gyki 53655 and Drug Withdrawal Symptoms

Article	Year
The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal. Neuropharmacology, 2003, Volume: 44, Issue:1 Topics: Allosteric Regulation; Animals; Behavior, Animal; Benzodiazepines; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Antagonists; Isoquinolines; Locus Coeruleus; Male; Morphine; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Substance Withdrawal Syndrome	2003

Article

Year

The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal.

Neuropharmacology, 2003, Volume: 44, Issue:1

Topics: Allosteric Regulation; Animals; Behavior, Animal; Benzodiazepines; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Antagonists; Isoquinolines; Locus Coeruleus; Male; Morphine; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Substance Withdrawal Syndrome

2003